Personalized Medicine May Get A Nanotechnology Boost
Wednesday, September 29, 2010 - 11:35
in Health & Medicine
A new technology can make nanoscale protein measurements - which may mean understanding the effects of therapeutic agents in tumor cells and different cell populations within patients, a key step toward being able to tailor therapy for each patient. Currently, research on cancer agent activity requires patients to undergo several invasive biopsies to generate enough cells for testing. A group of researchers have developed a highly sensitive test called the nano-immunoassay (NIA) that can make nanoscale protein measurements in cells from minimally invasive blood draws or fine-needle aspirates. The researchers used a microfluidic instrument called the Nanopro1000. read more